LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Non-hodgkin Lymphoma, B Cell
Interventions
DIAGNOSTIC_TEST

ctDNA detection

ctDNA detection on CSF and blood

Trial Locations (14)

1011

TERMINATED

CHUV - Départment d'oncologie, Lausanne

1205

RECRUITING

Hopitaux Universitaire de Genève (HUG), Geneva

1708

RECRUITING

Hôpital Fribourgeois - Hôpital Cantonal, Fribourg

1951

RECRUITING

Hôpital du Valais, Hôpital de Sion, Sion

3010

RECRUITING

Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern

4056

RECRUITING

Universitätsspital Basel, Basel

4410

RECRUITING

Kantonsspital Baselland, Liestal

5001

NOT_YET_RECRUITING

Kantonspital Aarau, Aarau

6500

WITHDRAWN

Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona

7000

RECRUITING

Kantonsspital Graubünden, Chur

8032

WITHDRAWN

Klinik für Hämatologie und Onkologie Hirslanden Zürich, Zurich

8063

RECRUITING

Stadtspital Triemli Zürich, Zurich

8596

RECRUITING

Kantonsspital Münsterlingen, Münsterlingen

9007

RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER